OS Therapies Inc. - Bathi mangsa ngarep OSTX

OSTX (OS Therapies Inc.) - tandha merek perusahaan

OS Therapies Incorporated (OSTX) is developing a portfolio of drugs against pediatric solid tumors, seeking partnerships with biotech giants. The specifics of osteosarcoma treatment render the business insensitive to macroeconomics and inflation. The expected net profit of the business is supported by this chart from GURU.Markets, which confirms a trend where the 0.00 parameter determines the metric's value. Management is focused on creating innovative immunotherapy for rare types of cancer.

OSTX: Bathi mangsa ngarep ostherapies.com 08.09.2024 - 03.04.2025

OS Therapies Inc - rincian analitis lan metrik utama (OSTX)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:OSTX, OS Therapies, Inc.
Barang utama OS Therapies Inc.

This metric determines the issuer's potential net income based on the balance of market supply and demand. The calculation is based on the extrapolation of current cash flows and is sensitive to any changes in financial reporting. By analyzing the expected net profit metric, an investor can filter out unfounded management optimism. For OS Therapies Incorporated (OSTX), this metric reflects the commercial viability of therapies for rare pediatric oncological diseases. Success in preserving patients' limbs converts directly into future capitalization.

Pesaing OS Therapies Incorporated

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake RADX|artivabio.com - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake